| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating | 
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.40% | $3.56B | €351.20B | 43.73% | 78 Outperform | |
| SAP SE | 1.01% | $2.55B | €261.78B | 1.36% | 73 Outperform | |
| HSBC Holdings | 0.90% | $2.27B | £184.65B | 52.00% | 79 Outperform | |
| Novartis AG | 0.88% | $2.22B | CHF187.47B | 3.30% | 78 Outperform | |
| Roche Holding AG | 0.85% | $2.16B | CHF208.68B | 3.85% | 73 Outperform | |
| Nestlé SA | 0.85% | $2.15B | CHF198.32B | 1.28% | 65 Neutral | |
| AstraZeneca | 0.84% | $2.13B | £194.71B | 12.08% | 75 Outperform | |
| Shell (UK) | 0.77% | $1.94B | £165.60B | 15.46% | 77 Outperform | |
| Royal Bank Of Canada | 0.76% | $1.93B | $206.19B | 18.70% | 75 Outperform | |
| Toyota Motor | 0.75% | $1.89B | ¥41.00T | 17.17% | 81 Outperform |